Model
Edge
Vanda Pharmaceuticals
0001802653
Filing Type
4
Filing Date
5/20/2024
Updated
5/21/24, 2:53 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership